Importantly, we uncovered that PPP2R2A regulates cell cycle progression, cell survival and VPA-mediated bidirectional response to HU treatment through PPP2R2A D197 and N181 in both tumor and normal cells. The gene discussed is PPP2R2A; the disease is neoplasm.